Thomas Lindsay
Directeur/Membre du Conseil chez GENEDRIVE PLC
Fortune : 16 859 $ au 30/04/2024
Postes actifs de Thomas Lindsay
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GENEDRIVE PLC | Directeur/Membre du Conseil | 09/04/2018 | - |
| TRINITY BIOTECH PLC | Directeur/Membre du Conseil | 26/10/2022 | - |
| Independent Dir/Board Member | 26/10/2022 | - | |
| Sales & Marketing | - | - |
Historique de carrière de Thomas Lindsay
Anciens postes connus de Thomas Lindsay
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Abbott Rapid Diagnostics ULC
 Abbott Rapid Diagnostics ULC Medical DistributorsDistribution Services Part of Abbott Laboratories, Abbott Rapid Diagnostics ULC is a world leader in rapid point of care (POC) solutions. The company's focus is on creating patient-centered diagnostic tests that can provide invaluable answers to doctors, healthcare professionals, and nurses when and where they are needed most. The company is based in Ottawa, Canada. The Canadian company provides innovative diagnostic tests for critical areas such as cardiology, infectious disease, and toxicology. | Corporate Officer/Principal | - | 01/01/2017 |
| NIGERIAN-GERMAN CHEMICALS PLC | Directeur/Membre du Conseil | 22/07/2011 | - |
Formation de Thomas Lindsay
| Glasgow Caledonian University | Undergraduate Degree |
Statistiques
Internationale
| Royaume-Uni | 3 |
| Nigéria | 2 |
| Canada | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NIGERIAN-GERMAN CHEMICALS PLC | Health Technology |
| GENEDRIVE PLC | Health Technology |
| TRINITY BIOTECH PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Abbott Rapid Diagnostics ULC
Abbott Rapid Diagnostics ULC Medical DistributorsDistribution Services Part of Abbott Laboratories, Abbott Rapid Diagnostics ULC is a world leader in rapid point of care (POC) solutions. The company's focus is on creating patient-centered diagnostic tests that can provide invaluable answers to doctors, healthcare professionals, and nurses when and where they are needed most. The company is based in Ottawa, Canada. The Canadian company provides innovative diagnostic tests for critical areas such as cardiology, infectious disease, and toxicology. | Distribution Services |
- Bourse
- Insiders
- Thomas Lindsay
- Expérience